The following table provides an overview of the latest patents of Biomarin Pharmaceutical Inc. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3461503May 11, 2022Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring5
EP3138566Jan 26, 2022Treatment Of Phenylketonuria With Bh43
EP3175863Dec 1, 2021Variants Of C-Type Natriuretic Peptide1
EP2545939Dec 16, 2020Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring5